体外循环后血小板Bax水平变化导致凝血酶诱导的血小板反应受损
前瞻性观察研究评估体外循环(CPB)心脏手术前后血小板Bax水平与血小板功能变化,发现CPB后血小板Bax表达增加,伴随血小板表面GPIb表达降低及凝血酶诱导的钙动员受损,体外实验证实Bax增加可模拟类似改变。
要点
- CPB后血小板Bax表达增加,尤其寡聚化形式,与血小板功能障碍相关。
- Bax增加导致血小板表面GPIb表达降低和凝血酶诱导钙动员受损。
- Bcl-xL或线粒体外膜通透性及TACE抑制剂可逆转凋亡样血小板改变。
核心结论
- CPB增加血小板Bax表达,导致血小板表面GPIb表达降低和凝血酶诱导的钙变化,可能参与CPB后血小板功能障碍。
研究设计与样本
- 前瞻性观察性临床与实验室研究,纳入体外循环和非体外循环冠状动脉旁路移植术患者各20例,另在8名健康志愿者中评估体外Bax增加效应。
主要发现
- 凝血酶诱导的血小板钙动员和血小板表面GPIb表达在脱离CPB时最低,术后第一天未恢复。
- 体外循环增加血小板Bax表达,尤其是寡聚化形式,并伴随Bax从胞质向线粒体转位及血小板表面TACE表达增加。
- 线粒体细胞色素c表达减少,非体外循环手术患者变化方向相似但幅度较小。
- 体外细胞通透性Bax肽增加血小板Bax至类似CPB水平,并产生类似血小板改变。
- Bcl-xL预给药大部分逆转凋亡样改变,联合抑制线粒体外膜通透性和TACE完全逆转。
临床怎么用
- CPB后血小板Bax相关凋亡信号可能成为改善血小板功能的潜在靶点。
- Bcl-xL或线粒体外膜通透性及TACE抑制剂在体外可逆转血小板凋亡样改变,但尚未临床验证。
局限性
- 研究为观察性设计,样本量有限(体外循环和非体外循环各20例,体外实验8例)。
- 体外实验结果不能直接外推至临床患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anucleate platelets can undergo apoptosis in response to various stimuli, as do nucleated cells. Cardiopulmonary bypass (CPB) causes platelet dysfunction and can also activate platelet apoptotic pathways. We therefore evaluated time-dependent changes in blood platelet Bax (a pro-apoptotic molecule) levels and platelet dysfunction after cardiac surgery. METHODS: We assessed blood samples obtained from subjects having on-pump or off-pump coronary artery bypass graft surgery ( n =20 each). We also evaluated the in vitro effects of platelet Bax increase in eight healthy volunteers. RESULTS: Thrombin-induced platelet calcium mobilisation and platelet-surface glycoprotein Ib (GPIb) expression were lowest at weaning from CPB and did not recover on postoperative day one. On-pump surgery increased platelet expression of Bax, especially the oligomerised form, along with translocation of Bax from the cytosol to mitochondria and platelet-surface tumour necrosis factor-alpha (TNF-α)-converting enzyme (TACE) expression. In contrast, mitochondrial cytochrome c expression was reduced. While similar in direction, the magnitude of the observed changes was smaller in patients having off-pump surgery. In vitro , a cell-permeable Bax peptide increased platelet Bax expression to the same extent seen during bypass and produced similar platelet changes. These apoptotic-like changes were largely reversed by Bcl-xL pre-administration, and were completely reversed by combined application of inhibitors that stabilise outer mitochondrial membrane permeability and TACE. CONCLUSIONS: CPB increases platelet Bax expression, which contributes to reduced platelet-surface GPIb expression and thrombin-induced platelet calcium changes. These changes in platelet apoptotic signalling might contribute to platelet dysfunction after CPB. CLINICAL TRIAL REGISTRATION: UMIN Clinical Trials Registry (number UMIN000006033).
引用
- Murase M, Nakayama Y, Sessler DI, et al. Changes in platelet Bax levels contribute to impaired platelet response to thrombin after cardiopulmonary bypass: prospective observational clinical and laboratory investigations. Br J Anaesth. 2017. PMID: 29040496. doi:10.1093/bja/aex349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。